These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17576338)

  • 1. Differentiating spitzoid melanomas from Spitz nevi through CD99 expression.
    King MS; Porchia SJ; Hiatt KM
    J Cutan Pathol; 2007 Jul; 34(7):576-80. PubMed ID: 17576338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of p16 alone does not differentiate between Spitz nevi and Spitzoid melanoma.
    Mason A; Wititsuwannakul J; Klump VR; Lott J; Lazova R
    J Cutan Pathol; 2012 Dec; 39(12):1062-74. PubMed ID: 23005921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropilin-2 as a useful marker in the differentiation between Spitzoid malignant melanoma and Spitz nevus.
    Wititsuwannakul J; Mason AR; Klump VR; Lazova R
    J Am Acad Dermatol; 2013 Jan; 68(1):129-37. PubMed ID: 22954749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging mass spectrometry--a new and promising method to differentiate Spitz nevi from Spitzoid malignant melanomas.
    Lazova R; Seeley EH; Keenan M; Gueorguieva R; Caprioli RM
    Am J Dermatopathol; 2012 Feb; 34(1):82-90. PubMed ID: 22197864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunohistochemical profile of Spitz nevi and conventional (non-Spitzoid) melanomas: a baseline study.
    Garrido-Ruiz MC; Requena L; Ortiz P; Pérez-Gómez B; Alonso SR; Peralto JL
    Mod Pathol; 2010 Sep; 23(9):1215-24. PubMed ID: 20543820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p16 expression: a marker of differentiation between childhood malignant melanomas and Spitz nevi.
    Al Dhaybi R; Agoumi M; Gagné I; McCuaig C; Powell J; Kokta V
    J Am Acad Dermatol; 2011 Aug; 65(2):357-363. PubMed ID: 21550132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the expression of vimentin and actin in spitz nevi and spitzoid malignant melanomas.
    Alomari AK; Klump V; Neumeister V; Ariyan S; Narayan D; Lazova R
    Am J Dermatopathol; 2015 Jan; 37(1):46-51. PubMed ID: 25548991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of mutations in B-RAF, N-RAS, and H-RAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma.
    van Dijk MC; Bernsen MR; Ruiter DJ
    Am J Surg Pathol; 2005 Sep; 29(9):1145-51. PubMed ID: 16096402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PRAME immunohistochemistry of spitzoid neoplasms.
    Koh SS; Lau SK; Scapa JV; Cassarino DS
    J Cutan Pathol; 2022 Aug; 49(8):709-716. PubMed ID: 35488519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intradermal spitz nevi: a rare subtype of spitz nevi analyzed in a clinicopathologic study of 74 cases.
    Plaza JA; De Stefano D; Suster S; Prieto VG; Kacerovska D; Michal M; Sangueza M; Kazakov DV
    Am J Dermatopathol; 2014 Apr; 36(4):283-94; quiz 295-7. PubMed ID: 24736667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of p16-Ki-67-HMB45 score in sorting benign from malignant Spitz tumors.
    Garola R; Singh V
    Pathol Res Pract; 2019 Oct; 215(10):152550. PubMed ID: 31351802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S100A6 protein expression is different in Spitz nevi and melanomas.
    Ribé A; McNutt NS
    Mod Pathol; 2003 May; 16(5):505-11. PubMed ID: 12748257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative immunohistochemical study of MART-1 expression in Spitz nevi, ordinary melanocytic nevi, and malignant melanomas.
    Bergman R; Azzam H; Sprecher E; Manov L; Munichor M; Friedman-Birnbaum R; Ben-Itzhak O
    J Am Acad Dermatol; 2000 Mar; 42(3):496-500. PubMed ID: 10688724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoreactivity of CD99 in invasive malignant melanoma.
    Wilkerson AE; Glasgow MA; Hiatt KM
    J Cutan Pathol; 2006 Oct; 33(10):663-6. PubMed ID: 17026517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic utility of low-affinity nerve growth factor receptor (P 75) immunostaining in atypical fibroxanthoma.
    Bull C; Mirzabeigi M; Laskin W; Dubina M; Traczyc T; Guitart J; Gerami P
    J Cutan Pathol; 2011 Aug; 38(8):631-5. PubMed ID: 21623867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ciliation Index Is a Useful Diagnostic Tool in Challenging Spitzoid Melanocytic Neoplasms.
    Lang UE; Torres R; Cheung C; Vladar EK; McCalmont TH; Kim J; Judson-Torres RL
    J Invest Dermatol; 2020 Jul; 140(7):1401-1409.e2. PubMed ID: 31978411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of p15 in a spectrum of spitzoid melanocytic neoplasms.
    Ma SA; O'Day CP; Dentchev T; Takeshita J; Ridky TW; Seykora JT; Chu EY
    J Cutan Pathol; 2019 May; 46(5):310-316. PubMed ID: 30666677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nestin Expression in Spitzoid Lesions: An Immunohistochemical Characterization With Clinical and Dermoscopic Correlations.
    Guanziroli E; Del Gobbo A; Coggi A; Venegoni L; Fanoni D; Ercoli G; Boggio F; Veraldi S; Cavicchini S; Berti E; Ferrero S; Gianotti R
    Appl Immunohistochem Mol Morphol; 2019 Jul; 27(6):430-435. PubMed ID: 30212379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Problematic lesions in children.
    Moscarella E; Piccolo V; Argenziano G; Lallas A; Longo C; Castagnetti F; Pizzigoni S; Zalaudek I
    Dermatol Clin; 2013 Oct; 31(4):535-47, vii. PubMed ID: 24075543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification of Indeterminate Melanocytic Lesions by MicroRNA Profiling.
    Latchana N; Del Campo SE; Grignol VP; Clark JR; Albert SP; Zhang J; Wei L; Aldrink JH; Nicol KK; Ranalli MA; Peters SB; Gru A; Trihka P; Payne PR; Howard JH; Carson WE
    Ann Surg Oncol; 2017 Feb; 24(2):347-354. PubMed ID: 27469124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.